{"denoms":[{"counts":[{"groupId":"BG000","value":"142"}],"units":"Participants"}],"groups":[{"description":"Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.","id":"BG000","title":"Bone Marrow Transplant"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"123"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"21","upperLimit":"66","value":"47"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"66"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"76"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}